Skip to main content
. 2019 Oct 23;43(2):246–253. doi: 10.1007/s00270-019-02350-2

Table 2.

Systemic radionuclide treatment details prior to radioembolization in 44 patients

Systemic treatment Number of patients Number of cycles Cumulative activity (GBq)
Median Range Median Range
131I-MIBG only 1 2 NA 14.8 NA
90Y-DOTATOC only 3 2 2–5 15.2 10–37
177Lu-DOTATATE only 31 4 3–9 30.8 10–61.6
131I-MIBG + 90Y-DOTATOC 1 1 + 1 NA 11 + 18.6 NA
90Y- + 177Lu-PRRT 8 2 + 1 1–5 + 1–4 15.2 + 14.8 7.4–32.3 + 7.4–23.3
Total 44 4 2–9 30.4 10–61.6

NA not applicable